Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been living permanently in Jakarta, Surabaya, or Yogyakarta City for at least 6 months
- People who are generally healthy with no known illnesses
- Male or female adolescents between the ages of 12 and 17 years old
- People who are overweight or obese, based on a body mass index (BMI) measurement that is above the normal range for their age
- People who have received at least two doses of the CoronaVac® (Sinovac) COVID-19 vaccine specifically
- People whose last CoronaVac® vaccine dose was given at least 6 months before joining the trial
- People whose parents or guardians are willing to sign a consent form, and who are themselves willing to agree to participate
- People who have active health insurance, such as BPJS or a similar plan
Who may not be able to join:
- People who have had a confirmed COVID-19 infection in the past month, confirmed by a PCR or antigen test from a health facility or laboratory
- People who have a history of long-term (chronic) illnesses, non-communicable diseases, conditions present from birth, or disabilities
- People who have been diagnosed with or are suspected of having active Tuberculosis (TB) in any form
- People who have had a digestive or nutrient absorption condition (such as celiac disease or inflammatory bowel disease) in the past three months or during the study period
- People who have taken antibiotics within 2 weeks before the study starts (the trial site may consider including someone after 3 weeks have passed since their last antibiotic dose)
- People who are taking medications or have conditions that may affect the immune system, such as immune deficiencies, medicines that suppress the immune system, or recent blood transfusions or blood products
- People who are taking insulin or cholesterol-lowering (anti-dyslipidemia) medications
- People who are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rina Agustina, PhD, Dep of Nutrition and Human Nutrition Research Center, IMERI, Fac of Medicine Universitas Indonesia
Phone: +622129189160
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
BMI-for-age z-scores (BAZ); Immunoglobulin G (IgG) specific to SARS-COV-2 titer concentrations
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.